Skip to content
PubMed This is a summary of 65 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 65 referenced papers

Top Authors

Leif G. Hanitsch
Humboldt-Universität zu Berlin
Joris M. van Montfrans
Utrecht University
Xavier Solanich
Bellvitge University Hospital
Charlotte Cunningham‐Rundles
Icahn School of Medicine at Mount Sinai
Hassan Abolhassani
Karolinska Institutet
Hilary J Longhurst
University of Auckland
Isabelle Meyts
Universitair Ziekenhuis Leuven
Filomeen Haerynck
Ghent University Hospital
Silvia Sánchez‐Ramón
Universidad Complutense de Madrid
Helen Baxendale
Royal Papworth Hospital

Top Institutions

Ranked by publications Top 10 institutions
09

Bellvitge University Hospital

Barcelona, Spain

7 papers

References

References (65)
  1. 1

    Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

    Richards S, Aziz N, Bale S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.

    PMID: 25741868
  2. 2

    [Infection due to Mycobacterium bovis in common variable immunodeficiency].

    Herrera-Sánchez DA, Castilla-Rodríguez JL, Castrejón-Vázquez MI, et al.

    Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2015; (62(1)):75-82.

    PMID: 25758115
  3. 3

    Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder.

    Keller MD, Pandey R, Li D, et al.

    The Journal of allergy and clinical immunology 2016; (138(2)):544-550.e4.

    PMID: 27016798
  4. 4

    Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets.

    Yazdani R, Seify R, Ganjalikhani-Hakemi M, et al.

    Allergologia et immunopathologia 2017; (45(2)):183-192 doi:10.1016/j.aller.2016.07.001.

    PMID: 27717724
  5. 5

    Identification and Characterization of a Nationwide Danish Adult Common Variable Immunodeficiency Cohort.

    Westh L, Mogensen TH, Dalgaard LS, et al.

    Scandinavian journal of immunology 2017; (85(6)):450-461 doi:10.1111/sji.12551.

    PMID: 28370285
  6. 6

    Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide Response.

    Schaballie H, Bosch B, Schrijvers R, et al.

    Frontiers in immunology 2017; (8()):546 doi:10.3389/fimmu.2017.00546.

    PMID: 28553290
  7. 7

    Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry.

    Feuille EJ, Anooshiravani N, Sullivan KE, et al.

    Journal of clinical immunology 2018; (38(1)):28-34 doi:10.1007/s10875-017-0456-9.

    PMID: 29080979
  8. 8

    Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland.

    Edgar JDM, Richter AG, Huissoon AP, et al.

    Journal of clinical immunology 2018; (38(2)):204-213 doi:10.1007/s10875-017-0469-4.

    PMID: 29423883
  9. 9

    Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.

    Tuijnenburg P, Lango Allen H, Burns SO, et al.

    The Journal of allergy and clinical immunology 2018; (142(4)):1285-1296 doi:10.1016/j.jaci.2018.01.039.

    PMID: 29477724
  10. 10

    What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review.

    Jones GL, Vogt KS, Chambers D, et al.

    Frontiers in immunology 2018; (9()):1308 doi:10.3389/fimmu.2018.01308.

    PMID: 30034388
  11. 11

    Fatigue and the wear-off effect in adult patients with common variable immunodeficiency.

    Hajjar J, Kutac C, Rider NL, et al.

    Clinical and experimental immunology 2018; (194(3)):327-338 doi:10.1111/cei.13210.

    PMID: 30168848
  12. 12

    Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Disorders: Experience from a Referral Center in India.

    Uppuluri R, Jayaraman D, Sivasankaran M, et al.

    Indian pediatrics 2018; (55(8)):661-664.

    PMID: 30218511
  13. 13

    Gastric Cancer Screening in Common Variable Immunodeficiency.

    van der Poorten DK, McLeod D, Ahlenstiel G, et al.

    Journal of clinical immunology 2018; (38(7)):768-777 doi:10.1007/s10875-018-0546-3.

    PMID: 30219982
  14. 14

    A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement.

    Więsik-Szewczyk E, Jahnz-Różyk K

    Medicine 2018; (97(44)):e12804 doi:10.1097/MD.0000000000012804.

    PMID: 30383634
  15. 15

    Common Variable Immunodeficiency-Associated Inflammatory Enteropathy: The New Era of Biological Therapy.

    Arieira C, Dias de Castro F, Moreira MJ, Cotter J

    GE Portuguese journal of gastroenterology 2018; (25(6)):322-326 doi:10.1159/000486448.

    PMID: 30480050
  16. 16

    A High Prevalence of Gastrointestinal Manifestations in Common Variable Immunodeficiency.

    Pikkarainen S, Martelius T, Ristimäki A, et al.

    The American journal of gastroenterology 2019; (114(4)):648-655 doi:10.14309/ajg.0000000000000140.

    PMID: 30747770
  17. 17

    IRF2BP2: A new player in the regulation of cell homeostasis.

    Ramalho-Oliveira R, Oliveira-Vieira B, Viola JPB

    Journal of leukocyte biology 2019; (106(3)):717-723 doi:10.1002/JLB.MR1218-507R.

    PMID: 31022319
  18. 18

    Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency.

    Crescenzi L, Pecoraro A, Fiorentino A, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019; (51(11)):1599-1603 doi:10.1016/j.dld.2019.05.016.

    PMID: 31155490
  19. 19

    The evaluation of neutropenia in common variable immune deficiency patients.

    Ghorbani M, Fekrvand S, Shahkarami S, et al.

    Expert review of clinical immunology 2019; (15(11)):1225-1233 doi:10.1080/1744666X.2020.1677154.

    PMID: 31592698
  20. 20

    Lung disease in patients with common variable immunodeficiency.

    López AL, Paolini MV, Fernández Romero DS

    Allergologia et immunopathologia 2020; (48(6)):720-728 doi:10.1016/j.aller.2020.04.001.

    PMID: 32446785
  21. 21

    Defining Common Variable Immunodeficiency Disorders in 2020.

    Ameratunga R, Allan C, Woon ST

    Immunology and allergy clinics of North America 2020; (40(3)):403-420 doi:10.1016/j.iac.2020.03.001.

    PMID: 32654689
  22. 22

    PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency.

    Zhang S, Kline M, Fuleihan RL, et al.

    Immunologic research 2020; (68(6)):379-388 doi:10.1007/s12026-020-09162-4.

    PMID: 33161558
  23. 23

    Comparison of Two Different Criteria for Specific Antibody Deficiency in Patients With Chronic and Recurrent Rhinosinusitis.

    Chernikova D, Stiehm R, Estevez D, Song CH

    Allergy & rhinology (Providence, R.I.) 2020; (11()):2152656720980408 doi:10.1177/2152656720980408.

    PMID: 33403153
  24. 24

    State-of-the-art diagnostic evaluation of common variable immunodeficiency.

    Lee TK, Gereige JD, Maglione PJ

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2021; (127(1)):19-27 doi:10.1016/j.anai.2021.03.005.

    PMID: 33716149
  25. 25

    Lessons Learned From the Clinical Presentation of Common Variable Immunodeficiency Disorders: A Systematic Review and Meta-Analysis.

    Janssen LMA, van der Flier M, de Vries E

    Frontiers in immunology 2021; (12()):620709 doi:10.3389/fimmu.2021.620709.

    PMID: 33833753
  26. 26

    Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.

    Li J, Lei WT, Zhang P, et al.

    The Journal of experimental medicine 2021; (218(11)) doi:10.1084/jem.20210566.

    PMID: 34473196
  27. 27

    Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID).

    Zhan W, Hatchette T, Yue F, et al.

    Pathogens & immunity 2021; (6(2)):105-118 doi:10.20411/pai.v6i2.405.

    PMID: 34988341
  28. 28

    Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review.

    Lee EY, Betschel S, Grunebaum E

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):21 doi:10.1186/s13223-022-00661-7.

    PMID: 35264237
  29. 29

    The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency: Daily practice performance in a tertiary university hospital.

    Neirinck J, Emmaneel A, Buysse M, et al.

    Frontiers in immunology 2022; (13()):937738 doi:10.3389/fimmu.2022.937738.

    PMID: 36177024
  30. 30

    Novel mutation and expanding phenotype in IRF2BP2 deficiency.

    Körholz J, Gabrielyan A, Sczakiel HL, et al.

    Rheumatology (Oxford, England) 2023; (62(4)):1699-1705 doi:10.1093/rheumatology/keac575.

    PMID: 36193988
  31. 31

    Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease.

    Daza-Cajigal V, Segura-Guerrero M, López-Cueto M, et al.

    Frontiers in immunology 2023; (14()):1197361 doi:10.3389/fimmu.2023.1197361.

    PMID: 37342345
  32. 32

    Case Report: A novel IRF2BP2 mutation in an IEI patient with recurrent infections and autoimmune disorders.

    Pan Y, Shang G, Li J, et al.

    Frontiers in immunology 2023; (14()):967345 doi:10.3389/fimmu.2023.967345.

    PMID: 37350971
  33. 33

    Novel frameshift variants expand the map of the genetic defects in IRF2BP2.

    García-Aznar JM, Maneiro Pampín E, García Ramos M, et al.

    Frontiers in immunology 2023; (14()):1279171 doi:10.3389/fimmu.2023.1279171.

    PMID: 37876937
  34. 34

    Pyopericardium presenting as pericardial tamponade in a patient with common variable immunodeficiency disorder.

    Windels A, Neri I, Conceição C, Osório J

    BMJ case reports 2023; (16(10)) doi:10.1136/bcr-2023-255362.

    PMID: 37899079
  35. 35

    Endoscopic and histopathological hints on infections in patients of common variable immunodeficiency disorder with gastrointestinal symptoms.

    Chen Y, You Y, Li J, et al.

    BMC gastroenterology 2023; (23(1)):413 doi:10.1186/s12876-023-03052-3.

    PMID: 38017379
  36. 36

    Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients.

    Hanitsch LG, Steiner S, Schumann M, et al.

    Frontiers in immunology 2023; (14()):1268207 doi:10.3389/fimmu.2023.1268207.

    PMID: 38187397
  37. 37

    Primary Immunodeficiency: Specific antibody deficiency with normal IgG.

    Hatcher VR, Alix VC, Hellu TS, Schuldt MM

    Allergy and asthma proceedings 2024; (45(5)):321-325 doi:10.2500/aap.2024.45.240057.

    PMID: 39294904
  38. 38

    Immunodeficiency: Burden of Illness.

    Hsueh JC, Van Hersh AT, Zhao W

    Allergy and asthma proceedings 2024; (45(5)):294-298 doi:10.2500/aap.2024.45.240060.

    PMID: 39294910
  39. 39

    The role of immunophenotyping in common variable immunodeficiency: a narrative review.

    Neirinck J, Buysse M, De Vriendt C, et al.

    Critical reviews in clinical laboratory sciences 2025; (62(2)):65-84 doi:10.1080/10408363.2024.2404842.

    PMID: 39364936
  40. 40

    Intrinsic functional defects in B cells of patients with NFKB2 mutations.

    Min Q, Li Y, Wu X, et al.

    Clinical and experimental immunology 2025; (219(1)) doi:10.1093/cei/uxae090.

    PMID: 39405181
  41. 41

    A patient with CVID-enteropathy successfully treated with ustekinumab.

    Marley F, Lockett M, Gompels M, Grammatikos A

    Immunologic research 2024; (73(1)):19 doi:10.1007/s12026-024-09559-5.

    PMID: 39694957
  42. 42

    Monogenic Common Variable Immunodeficiency (Mo-CVID) Score for Optimizing the Genetic Diagnosis in Pediatric CVID Cohort.

    Barbati F, Lodi L, Boscia S, et al.

    European journal of immunology 2025; (55(3)):e202451433 doi:10.1002/eji.202451433.

    PMID: 40079712
  43. 43

    IRF2BP2 deficiency: An important form of common variable immunodeficiency with inflammation.

    Udemgba C, Pillay B, Shafer S, et al.

    The Journal of allergy and clinical immunology 2025; (155(6)):2052-2062.e5 doi:10.1016/j.jaci.2025.02.038.

    PMID: 40090425
  44. 44

    Polyautoimmunity Reflecting Immune Dysregulation in Common Variable Immunodeficiency.

    Danieli MG, Murdaca G, Mezzanotte C, et al.

    Biomedicines 2025; (13(3)) doi:10.3390/biomedicines13030552.

    PMID: 40149529
  45. 45

    An IRF2BP2 Variant in a Pediatric Patient with Common Variable Immunodeficiency.

    Tekcan D, Ceylan A, Kulhas Celik I, Artac H

    Pediatric allergy, immunology, and pulmonology 2025; (38(3)):100-104 doi:10.1177/2151321X251360561.

    PMID: 40689779
  46. 46

    Multiplexed assays of variant effect for clinical variant interpretation.

    McEwen AE, Tejura M, Fayer S, et al.

    Nature reviews. Genetics 2026; (27(2)):137-154 doi:10.1038/s41576-025-00870-x.

    PMID: 40691352
  47. 47

    Reassessing Polysaccharide Responsiveness: Unveiling Limitations of Current Guidelines and Introducing the Polysaccharide Responsiveness Percentile Approach.

    Fogsgaard SF, Todaro S, Larsen CS, et al.

    Journal of clinical immunology 2025; (45(1)):115.

    PMID: 40711631
  48. 48

    Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide study.

    Moral Moral P, Garcia-Bustos V, Balastegui-Martin H, et al.

    Frontiers in immunology 2025; (16()):1640290 doi:10.3389/fimmu.2025.1640290.

    PMID: 40771807
  49. 49

    Immunoglobulin G Trough Levels and Infection Risk in Adults with Inborn Errors of Immunity Receiving Immunoglobulin Therapy.

    Aktaş ÖÖ, Özer NO, Kaplankıran C, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(9)) doi:10.3390/medicina61091549.

    PMID: 41010940
  50. 50

    CVID Enteropathy Is Difficult To Treat and Shows a Heterogeneous Histopathology.

    Juliana NM, Severs M, Marsden JW, et al.

    Journal of clinical immunology 2025; (45(1)):129.

    PMID: 41026260
  51. 51

    Common variable immunodeficiency.

    Solanich X, Antolí A, Alsina L

    Medicina clinica 2025; (165(5)):107168 doi:10.1016/j.medcli.2025.107168.

    PMID: 41045774
  52. 52

    The Presentation, Diagnosis, and Management of Autosomal Dominant Common Variable Immunodeficiency Type XII with NFKB1 Mutation and Autoimmune Neutropenia Treated with Allogenic Stem Cell Transplantation.

    Gold M, Kannan C, Schofield A, et al.

    Hematology reports 2025; (17(5)) doi:10.3390/hematolrep17050049.

    PMID: 41148944
  53. 53

    When immunity turns rogue: lymphoma and lymphoproliferative disorders in common variable immune deficiency.

    Sciacca B, Franco M, Gualtiero G, et al.

    Current opinion in allergy and clinical immunology 2025; (25(6)):444-454 doi:10.1097/ACI.0000000000001121.

    PMID: 41158013
  54. 54

    Case Report: Novel IRF2BP2 variant in a Japanese patient with impaired B-cell differentiation, Th1 polarization, and systemic immune dysregulation.

    Endo Y, Koga T, Kurushima S, et al.

    Frontiers in immunology 2025; (16()):1662899 doi:10.3389/fimmu.2025.1662899.

    PMID: 41246352
  55. 55

    Current concepts: Common variable immunodeficiency.

    Cunningham-Rundles C

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2026; (136(4)):376-386 doi:10.1016/j.anai.2025.11.009.

    PMID: 41274495
  56. 56

    Common Variable Immunodeficiency Disorders: A perspective from New Zealand.

    Ameratunga R, J Longhurst H, Lehnert K, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.

    PMID: 41324804
  57. 57

    Enteropathy in Common Variable Immunodeficiency.

    Grammatikos A

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1540-1545 doi:10.1016/j.jaip.2026.03.021.

    PMID: 41935739
  58. 58

    From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy.

    Lang A, Agharahimi A, Vogel TP, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1506-1514 doi:10.1016/j.jaip.2026.03.041.

    PMID: 41999916
  59. 59

    Clinical practice guideline for the diagnosis of granulomatous-lymphocytic interstitial lung disease in patients with common variable immunodeficiency disorders: an ERS Clinical Research Collaboration.

    Bintalib HM, van de Ven AAJM, Rojas-Reyes MX, et al.

    The European respiratory journal 2026; (68(3)) doi:10.1183/13993003.02224-2025.

    PMID: 42350065
  60. 60

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  61. 61

    Does CVID exist in children? A genetic architecture and manifestation map derived from 7,525 patients.

    Gkantaras A, , Seidel MG

    Journal of human immunity 2026; (2(5)):e20260091 doi:10.70962/jhi.20260091.

    PMID: 42495711
  62. 62

    Gastrointestinal manifestations of common variable immunodeficiency: what a gastroenterologist needs to be aware of.

    Levy DM, Meriwether M, Schwartz MR, et al.

    Expert review of gastroenterology & hepatology 2026; (20(8)):673-682 doi:10.1080/17474124.2026.2716136.

    PMID: 42557929
  63. 63

    Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

    Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.

    Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.

    PMID: 42676356
  64. 64

    Memory B Cells and Antibody Responses to Vaccines in Infected Children (MARVIC) With Recurrent Infections: Protocol for a Prospective Observational Study.

    Jamaluddin J, Mohamad SM, Zainal Abidin MA, et al.

    JMIR research protocols 2026; (15()):e101835 doi:10.2196/101835.

    PMID: 42867869
  65. 65

    Vedolizumab treatment in adults with immunodeficiency-associated enteropathy: a case series.

    Angarola E, Etchevers MJ, De Paula JA, et al.

    Frontiers in immunology 2026; (17()):1953966 doi:10.3389/fimmu.2026.1953966.

    PMID: 42898158